Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. (ANTH) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
ANTH · net income · updated Jun 9, 2026
Core profitability metrics
ANTH · net income · margin · TTM · CAGRNet income was −$16.9M for FY2017 (fiscal year ending 2017-12-31), up 68.4% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · ANTH net income history · ANTH profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Anthera Pharmaceuticals, Inc. (ANTH) reported net income of −$16.9M for FY2017 (fiscal year ending 2017-12-31), up 68.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Anthera Pharmaceuticals, Inc. has not yet achieved annual profitability based on available data (13 fiscal years). The company has reported net losses across all available periods.
Anthera Pharmaceuticals, Inc.'s net profit margin was — for FY2017, based on the latest annual results.
Investors sometimes search for "Anthera Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from ANTH net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
ANTH net income · 4 questionsAnthera Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $16.9M for FY2017.
▸ Source: FMP /income-statement · GAAP · Anthera Pharmaceuticals, Inc. · Anthera Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026